Intervention Review

Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children

  1. Aikaterini Tzortzopoulou1,*,
  2. M Soledad Cepeda2,
  3. Roman Schumann1,
  4. Daniel B Carr3

Editorial Group: Cochrane Anaesthesia Group

Published Online: 16 JUL 2008

Assessed as up-to-date: 2 SEP 2007

DOI: 10.1002/14651858.CD006883.pub2

How to Cite

Tzortzopoulou A, Cepeda MS, Schumann R, Carr DB. Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children. Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No.: CD006883. DOI: 10.1002/14651858.CD006883.pub2.

Author Information

  1. 1

    Tufts Medical Center, Department of Anesthesiology, Boston, Massachusetts, USA

  2. 2

    Johnson & Johnson Pharmaceutical Research and Development, Pharmacoepidemiology, Titussville, NJ, USA

  3. 3

    Tufts University School of Medicine, Department of Public Health and Community Medicine, Boston, USA

*Aikaterini Tzortzopoulou, Department of Anesthesiology, Tufts Medical Center, 800 Washington street, Boston, Massachusetts, 02111, USA.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 16 JUL 2008


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.